Clinical trial
Real-world Study in Acute Leukemia: Epidemiology, Treatment Patterns and Outcomes for B-cell ALL and AML in Adult Patients From Latin America - LOYAL Study
NCT05166135 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Real-world Study in Acute Leukemia: Epidemiology, Treatment Patterns and Outcomes for B-cell ALL and AML in Adult Patients From Latin America - LOYAL Study
- Lead sponsor
- Pfizer
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 10, 2021
- Completion date
- November 15, 2022
- Enrollment
- 589 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.
acute lymphoid leukemia, acute myeloid leukemia